SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-011474
Filing Date
2023-04-03
Accepted
2023-04-03 08:00:23
Documents
14
Period of Report
2023-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prds-20230331.htm   iXBRL 8-K 85571
2 EX-99.1 prds-ex99_1.htm EX-99 79952
3 GRAPHIC img256556724_0.jpg GRAPHIC 19682
  Complete submission text file 0000950170-23-011474.txt   333187

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prds-20230331.xsd EX-101.SCH 2477
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prds-20230331_pre.xml EX-101.PRE 11974
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prds-20230331_lab.xml EX-101.LAB 17890
8 EXTRACTED XBRL INSTANCE DOCUMENT prds-20230331_htm.xml XML 5068
Mailing Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008 415-649-8758
PARDES BIOSCIENCES, INC. (Filer) CIK: 0001822711 (see all company filings)

IRS No.: 852696306 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40067 | Film No.: 23790671
SIC: 2834 Pharmaceutical Preparations